The Applied Immune Sciences pipeline

Applied Immune Sciences is pursuing clinical trials in four therapeutic areas: AIDS, bone marrow transplant, cancer and gene therapy.

There are three trials in AIDS: a 10-patient Phase I trial, and two 20-patient Phase II trials. In all three, the AIS CELLector device is used to harvest patients' CD8+ cells